Cabral-García Guillermo A, Cruz-Muñoz José R, Valdez-Morales Eduardo E, Barajas-Espinosa Alma, Liñán-Rico Andrómeda, Guerrero-Alba Raquel
Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico.
Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONAHCyT), Ciudad de México 03940, Mexico.
Pharmaceuticals (Basel). 2024 Sep 28;17(10):1291. doi: 10.3390/ph17101291.
The role of P2X ionotropic receptors in the behavior of purinergic signaling on pathophysiological processes has been widely studied. In recent years, the important participation of P2X receptors in physiological and pathological processes, such as energy metabolism, characteristic inflammatory responses of the immune system, and nociceptive activity in response to pain stimuli, has been noted. Here, we explore the molecular characteristics of the P2X receptors and the use of the different agonist and antagonist agents recently described, focusing on their potential as new therapeutic targets in the treatment of diseases with emphasis on obesity, diabetes, and some of the complications derived from these pathologies.
P2X离子型受体在嘌呤能信号传导对病理生理过程的作用已得到广泛研究。近年来,人们已经注意到P2X受体在生理和病理过程中的重要参与,如能量代谢、免疫系统的特征性炎症反应以及对疼痛刺激的伤害性感受活动。在此,我们探讨P2X受体的分子特征以及最近描述的不同激动剂和拮抗剂的应用,重点关注它们作为新治疗靶点在治疗肥胖、糖尿病以及这些病症衍生的一些并发症等疾病中的潜力。